Na-Z-L-histidine methyl ester, 98.0%, 5g

2-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole, 95+%, 5g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95+%, 5g

2-Nitro-6-(trifluoromethyl)aniline, 95.0%, 5g

4,4,5,5-Tetramethyl-2-(tetrahydro-2H-pyran-4-yl)-1,3,2-dioxaborolane, 95.0%, 100mg

N-acetil-D-galattosamina, minimo 99%, per biochimica, 250 mg, confezione in vetro

1-(Methylsulfanyl)propan-2-ol, 95%, 500mg

4,8-dichloro[1]benzofuro[3,2-d]pyrimidine, 97%, 1g

2-(1-pyrrolidinylmethyl)-1,4-oxazepane, 95.0%, 1g

Lead(II) Chloride (purified by sublimation) [for Perovskite precursor]>99.5%(T)5g

1-Iodo-2-phenoxybenzene, 95.0%, 250mg

2-Bromo-5-methylaniline, 98.0%, 100g

1,2,4-Trimethylbenzene>98.0%(GC)500mL